• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    AbbVie, Amgen, Lilly Urge FDA to Update Post-Approval Rules

    BIOSPACE

    AbbVie Healthcare under government lens for `violations`

    ECONOMICTIMES

    US FDA rejects AbbVie`s Parkinson`s disease therapy for the second time

    FIERCE PHARMA

    US FDA declines to approve Supernus` Parkinson`s combination again

    REUTERS

    Alvotech resubmits its interchangeable Humira biosim AbbVie clings

    ENDPTS

    AbbVie, Pfizer and Lilly JAK meds slapped with new warnings

    FIERCEPHARMA

    FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly

    REUTERS

    Insurers to squeeze JAK inhibitor access in chronic conditions after FDA warning

    PHARMACEUTICAL-TECHNOLOGY

    FDA warns Allergan over recalled breast implant safety studies

    FIERCE BIOTECH

    FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier & Vosevi

    FDA

    FDA issues safety warning for newer hepatitis C drugs following patient deaths

    BIOPHARMADIVE

    Allergan recalls textured breast implants worldwide

    REUTERS

    Roche, Biogen and AbbVie stake new gene therapy claims

    NATURE

    New Zealand Adopts Major Revision to Clinical Trial Rules

    RAPS

    EMA suspends, recalls doomed AbbVie and Biogen MS drug Zinbryta

    FIERCE PHARMA

    8 PDUFA Dates to Watch in August

    BIOSPACE

    AbbVie`s Humira needs a discount, ICER says, warning Lilly, Sanofi to price with care

    FIERCE PHARMA

    Misbranded epilepsy drug API lands FDA warning for Chinese ingredient maker

    IN PHARMATECHNOLOGIST

    Coherus` Humira formulation patent challenge rejected by PTAB

    BIOPHARMA

    U.S. FDA adds abuse warning to prescription testosterone

    REUTERS

    The FDA offers a controversial solution to the biosimilars name game

    FIERCE BIOTECH

    AbbVie Presses FDA to Make Biosimilar Labeling Show Differences from Reference Sponsor Labeling

    FDA

    Return of the Scarlet Letter? AbbVie Petitions FDA to Require Biosimilar Labeling to Include Disclaimers and a Description of Data Differences

    FDA LAW BLOG

    NICE recommends new licences for autoinflammatory disorders

    PHARMATIMES

    Biogen MA, Inc. v. Japanese Foundation for Cancer Research (Fed. Cir. 2015)

    PATENT DOCS

    Senator Asks Department of Veteran Affairs to Break Patents on Hepatitis C Drugs

    PATENT DOCS

    FDA Reaches Out to Minorities During Hepatitis Awareness Month

    FDA VOICE

    Medicaid Drug-Spending Hikes Rile Lawmakers, But There`s No End In Sight

    FIERCE PHARMA

    Hey, European Countries--Join Forces To Bring Down Drug Prices, WHO Suggests

    FIERCE PHARMA

    Hepatitis C Drugs are Cost Effective, but Affordability is Another Matter

    PHARMALOT

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.